艾普沃思嗜睡量表
持续气道正压
医学
多导睡眠图
优势比
多次睡眠潜伏期试验
麻醉
萧条(经济学)
物理疗法
白天过度嗜睡
阻塞性睡眠呼吸暂停
睡眠障碍
内科学
呼吸暂停
失眠症
精神科
经济
宏观经济学
作者
Rohit Budhiraja,Clete A. Kushida,Deborah A. Nichols,James K. Walsh,Richard Simon,Daniel J. Gottlieb,Stuart F. Quan
出处
期刊:The European respiratory journal
[European Respiratory Society]
日期:2017-11-01
卷期号:50 (5): 1700348-1700348
被引量:46
标识
DOI:10.1183/13993003.00348-2017
摘要
We evaluated factors associated with subjective and objective sleepiness at baseline and after 6 months of continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnoea (OSA).We analysed data from the Apnoea Positive Pressure Long-term Efficacy Study (APPLES), a prospective 6-month multicentre randomised controlled trial with 1105 subjects with OSA, 558 of who were randomised to active CPAP. Epworth sleepiness scale (ESS) scores and the mean sleep latency (MSL) on the maintenance of wakefulness test at baseline and after 6 months of CPAP therapy were recorded.Excessive sleepiness (ESS score >10) was present in 543 (49.1%) participants. Younger age, presence of depression and higher apnoea-hypopnoea index were all associated with higher ESS scores and lower MSL. Randomisation to the CPAP group was associated with lower odds of sleepiness at 6 months. The prevalence of sleepiness was significantly lower in those using CPAP >4 h·night-1versus using CPAP ≤4 h·night-1 Among those with good CPAP adherence, those with ESS >10 at baseline had significantly higher odds (OR 8.2, p<0.001) of persistent subjective sleepiness.Lower average nightly CPAP use and presence of sleepiness at baseline were independently associated with excessive subjective and objective sleepiness after 6 months of CPAP therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI